S51 Characterisation of exacerbations of severe eosinophilic asthma on mepolizumab compared to placebo

Mepolizumab reduces exacerbations of severe eosinophilic asthma. However, even with mepolizumab treatment, exacerbations still occur in this population.We have previously shown that exacerbations on mepolizumab are associated with lower sputum eosinophil counts and lower decrements in symptoms measu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thorax 2019-12, Vol.74 (Suppl 2), p.A35
Hauptverfasser:	Shrimanker, R, Keene, O, Bratton, DJ, Yancey, SW, Heaney, LG, Pavord, ID
Format:	Artikel
Sprache:	eng
Schlagworte:	Asthma Monoclonal antibodies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!